| NDC Code | 51662-1437-1 |
|---|
| Package Description | 2 mL in 1 VIAL, SINGLE-DOSE (51662-1437-1) |
|---|
| Product NDC | 51662-1437 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Clindamycin |
|---|
| Non-Proprietary Name | Clindamycin |
|---|
| Dosage Form | INJECTION, SOLUTION, CONCENTRATE |
|---|
| Usage | INTRAVENOUS |
|---|
| Start Marketing Date | 20200205 |
|---|
| End Marketing Date | 20200531 |
|---|
| Marketing Category Name | ANDA |
|---|
| Application Number | ANDA062800 |
|---|
| Manufacturer | HF Acquisition Co LLC, DBA HealthFirs |
|---|
| Substance Name | CLINDAMYCIN PHOSPHATE |
|---|
| Strength | 150 |
|---|
| Strength Unit | mg/mL |
|---|
| Pharmacy Classes | Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [CS] |
|---|